Breast cancer startup founded by WashU Medicine researchers acquired by Lunit (IMAGE)

WashU Medicine

Breast cancer startup founded by WashU Medicine researchers acquired by Lunit

Caption

WashU Medicine researchers Graham Colditz, MD, DrPH, (left) and Shu (Joy) Jiang, PhD, co-founded Prognosia, a biotech startup that harnesses AI-driven software to analyze mammograms to improve breast cancer risk prediction. Prognosia has been acquired by Lunit, a leading company developing AI-based technology for cancer prevention and early detection.

Credit

Joe Taylor

Usage Restrictions

Credit Joe Taylor

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.